Tirzepatide is currently the "heavy hitter" in the world of metabolic optimization. While older peptides focus on one pathway, Tirzepatide is a dual-agonist, meaning it hits two different receptors (GLP-1 and GIP) simultaneously to deliver a one-two punch to body fat and appetite.
